Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 5MB, 226 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website. 

 

 

Export 15 results:
Author [ Title(Desc)] Type Year
Filters: Author is Card, T.  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
5
T. P. van Staa, Card, T., Logan, R. F., and Leufkens, H. G., “5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study”, Gut, vol. 54, pp. 1573-8, 2005.
A
A. A. Sultan, West, J., Ban, L., Humes, D., Tata, L. J., Fleming, K. M., Nelson-Piercy, C., and Card, T., “Adverse Pregnancy Outcomes Among Women with Inflammatory Bowel Disease: A Population-Based Study from England”, Inflamm Bowel Dis, vol. 22, pp. 1621-30, 2016.
T. Card, Logan, R. F., Rodrigues, L. C., and Wheeler, J. G., “Antibiotic use and the development of Crohn's disease”, Gut, vol. 53, pp. 246-50, 2004.
C
C. Canavan, West, J., and Card, T., “Calculating Total Health Service Utilisation and Costs from Routinely Collected Electronic Health Records Using the Example of Patients with Irritable Bowel Syndrome Before and After Their First Gastroenterology Appointment”, Pharmacoeconomics, vol. 34, pp. 181-94, 2016.
A. A. Sultan, Crooks, C. J., Card, T., Tata, L. J., Fleming, K. M., and West, J., “Causes of death in people with coeliac disease in England compared with the general population: a competing risk analysis”, Gut, vol. 64, pp. 1220-6, 2015.
D
C. Renzi, Lyratzopoulos, G., Card, T., Chu, T. P., Macleod, U., and Rachet, B., “Do colorectal cancer patients diagnosed as an emergency differ from non-emergency patients in their consultation patterns and symptoms? A longitudinal data-linkage study in England”, Br J Cancer, vol. 115, pp. 866-75, 2016.
G
L. J. Tata, West, J., Smith, C., Farrington, P., Card, T., Smeeth, L., and Hubbard, R., “General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction”, Heart, vol. 91, pp. 465-71, 2005.
H
T. Card, West, J., Hubbard, R., and Logan, R. F., “Hip fractures in patients with inflammatory bowel disease and their relationship to corticosteroid use: a population based cohort study”, Gut, vol. 53, pp. 251-5, 2004.
I
L. Grønbaek, Otete, H., Ban, L., Crooks, C., Card, T., Jepsen, P., and West, J., “Incidence, prevalence, and mortality of autoimmune hepatitis in England 1997-2015. A population-based cohort study”, Liver Int, 2020.
M
M. Solaymani-Dodaran, Logan, R. F., West, J., and Card, T., “Mortality associated with Barrett's esophagus and gastroesophageal reflux disease diagnoses-a population-based cohort study”, Am J Gastroenterol, vol. 100, pp. 2616-21, 2005.
T. Card, Hubbard, R., and Logan, R. F., “Mortality in inflammatory bowel disease: a population-based cohort study”, Gastroenterology, vol. 125, pp. 1583-90, 2003.
R
M. Solaymani-Dodaran, Aithal, G. P., Card, T., and West, J., “Risk of cardiovascular and cerebrovascular events in primary biliary cirrhosis: a population-based cohort study”, Am J Gastroenterol, vol. 103, pp. 2784-8, 2008.
M. Solaymani-Dodaran, Logan, R. F., West, J., Card, T., and Coupland, C., “Risk of extra-oesophageal malignancies and colorectal cancer in Barrett's oesophagus and gastro-oesophageal reflux”, Scand J Gastroenterol, vol. 39, pp. 680-5, 2004.
T
A. J. Walker, Card, T., Bates, T. E., and Muir, K., “Tricyclic antidepressants and the incidence of certain cancers: a study using the GPRD”, Br J Cancer, vol. 104, pp. 193-7, 2011.
W
G. Nakafero, Grainge, M. J., Card, T., Mallen, C. D., Zhang, W., Doherty, M., Taal, M. W., Aithal, G. P., and Abhishek, A., “What is the incidence of methotrexate or leflunomide discontinuation related to cytopenia, liver enzyme elevation or kidney function decline?”, Rheumatology (Oxford), 2021.
[Page last reviewed 6 April 2021]